Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

GP KFPs / SAQsaddiction-medicine

GP KFPs / SAQs · addiction-medicine

Alcohol use disorder — KFP-style written assessment

KFP-style staged scenarios on alcohol use disorder: AUDIT screening and brief intervention, naltrexone and acamprosate pharmacotherapy with JAMA meta-analysis data, alcohol withdrawal management with benzodiazepines and thiamine, and Wernicke encephalopathy prevention.

30 marks45 min2 min readVerification in progress

Target exams

RACGP KFPRACGP AKTMRCGP AKT
On this page
Study tools

Target exams

RACGP KFPRACGP AKTMRCGP AKT
Prompt
AUD: screen with AUDIT, intervene briefly, treat with naltrexone or acamprosate — screening, pharmacotherapy, withdrawal and thiamine

KFP 1 (10 marks)

A 45-year-old man presents for a routine health check. AUDIT-C score is 7 (positive). Full AUDIT-10 score is 18 (hazardous drinking). He drinks approximately 30 standard drinks per week. He is motivated to reduce but has never tried pharmacotherapy. [3]

  1. What brief intervention should you deliver? Describe the FRAMES structure. (4)
  2. What pharmacotherapy would you offer and what is the evidence? (4) [3]
  3. What monitoring applies during pharmacotherapy? (2) [3]

Model answers

  1. Brief intervention using the FRAMES structure: Feedback (his AUDIT score indicates hazardous drinking), Responsibility (the choice to change is his), Advice (clear recommendation to reduce), Menu (of options — reduce, stop, pharmacotherapy, counselling), Empathy (expressed throughout), Self-efficacy (build his confidence). Takes 5-10 minutes.
  2. Offer naltrexone 50 mg daily. The JAMA meta-analysis of 118 trials and 20,976 participants found naltrexone 50 mg reduced return to heavy drinking with NNT 11 versus placebo. Acamprosate 666 mg TDS is an alternative (NNT 11 for preventing return to any drinking). [3]
  3. Monitor LFTs before and during naltrexone (hepatotoxicity risk). Review at 2 weeks for side effects (nausea), then monthly. Assess adherence and drinking at each visit. Naltrexone is contraindicated with opioids — confirm he is not taking any. [3]
General Practice Pro

Continue reading

You have read the opening of this kfps / saq. The complete unit — every section and its primary-source references — is part of the General Practice fellowship library.

Sign in to continueSee pricing
References2ShowHide
  1. [1]Plosker GL Acamprosate: A Review of Its Use in Alcohol Dependence. Drugs, 2015.PMID 26084940
  2. [3]McPheeters M, O'Connor EA, Riley S, Kennedy SM, Voisin C, et al. Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. JAMA, 2023.PMID 37934220
General Practice Pro

$29/ monthor $279 / year

The complete General Practice library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousLung cancer suspicion — KFP-style written assessmentrespiratory-healthNextOpioid dependence treatment - KFP-style written assessmentaddiction-medicine